凝练中国血吸虫病防控成功经验贡献于WHO指南在全球实施

Contribution to global implementation of WHO guideline on control and elimination of human schistosomiasis by learning successful experiences from the national schistosomiasis control program in China

血吸虫病是一种严重阻碍社会经济发展、威胁公共卫生安全的寄生虫病。为实现2030年全球消除作为一种公共卫生问题的血吸虫病,2022年2月WHO发布了《WHO控制和消除人体血吸虫病指南》,旨在为各国实现控制血吸虫病发病率、将其作为一种公共卫生问题消除及最终达到传播阻断提供循证建议。在历史上血吸虫病曾经严重流行的中国,经过有效防控策略和措施的实施,血吸虫病防控工作取得了重大成绩,逐步迈向消除血吸虫病。本文回顾中国血吸虫病防控策略、防控关键技术和实践的成功经验,贡献于《WHO控制和消除人体血吸虫病指南》的制定与实施。随着“一带一路”倡议的深入推进,世界也期待更多血吸虫病防控领域的“中国方案”。

Schistosomiasis is a parasitic disease that seriously hinders socioeconomic developments and threatens public health security.To achieve the global elimination of schistosomiasis as a public health problem by 2030,WHO released the guideline on control and elimination of human schistosomiasis on February,2022,with aims to provide evidence⁃based recom⁃mendations for schistosomiasis morbidity control,elimination of schistosomiasis as a public health problem,and ultimate inter⁃ruption of schistosomiasis transmission in disease⁃endemic countries.Following concerted efforts for decades,great achievements have been obtained for schistosomiasis control in China where the disease was historically highly prevalent,and the country is moving towards schistosomiasis elimination.This article reviews the successful experiences from the national schistosmiasis con⁃trol program in China,and summarizes their contributions to the formulation and implementation of the WHO guideline on con⁃trol and elimination of human schistosomiasis.With the progress of the“Belt and Road”initiative,the world is looking forward to more China’s solutions on schistosomiasis control.